TAK250117P25000
- 0.00
- 0.000.00%
Takeda Pharmaceutical Newsroom
The Nikkei average started down 203 points, with declines in companies like Tokio Marine and Renesas ETC.
[Nikkei Stock Average and TOPIX (Table)] Nikkei Average; 39879.36; -203.94 TOPIX; 2775.66; -10.91 [Opening Overview] On the 8th, the Nikkei Average opened at 39879.36 yen, falling by 203.94 yen. The US stock market on the 7th declined. The Dow Inc decreased by 178.20 dollars to 42528.36 dollars, and the Nasdaq closed down by 375.30 points at 19489.68. The rise of Semiconductors NVIDIA (NVDA) is
List of cloud-breaking stocks [Ichimoku Kinko Hyo - List of cloud-breaking stocks]
○ List of stocks breaking above the clouds in the market Code Stock Name Closing Price Leading Span A Leading Span B Tokyo Main Board <1879> Shinjapan Ken 1564 1530 1563 <1934> Your Tech 1558 1476.75 1512.5 <2742> Hallows 4625 4207.54 325 <3141> Welcia HD 2054 1908.5 1974 <3252> Landlord 2160 2117.5
ANI Gets FDA Approval for Generic Motegrity
Takeda-backed Ascentage Pharma Files for $100M IPO
List of conversion stocks (Part 1) [Parabolic Signal Conversion Stocks]
○List of stocks undergoing Buy conversion in the market Code Stock Name Closing Price SAR Tokyo Main Board <1301> Kiyokyo 4115 3945 <1332> Nissui 900873 <1377> Sakata Seed 34703370 <1726> Br. HD 346330 <1802> Obayashi Corporation 21012025 <1808> Haseko Corporation 20491980 <1820> Nishimatsu Construction 52485066 <1887> Japan National.
ADR Japanese stock ranking - Overall selling pressure with Yu-cho Bank and others, Chicago is down 100 yen compared to Osaka at 40,130 yen.
Japanese stocks of American Depositary Receipts (ADR), when compared to the Tokyo Stock Exchange (calculated at 157.91 yen per dollar), saw declines in stocks such as Japan Post Bank <7182>, Advantest <6857>, Disco <6146>, SMC <6273>, DAIKIN INDUSTRIES, LTD. Unsponsored ADR <6367>, Toyota Motor <7203>, and Honda Motor <7267>, indicating a general trend of selling. The settlement price of the Chicago Nikkei 225 Futures was 40,130 yen, which is 100 yen lower than the daytime rate in Osaka. The US stock market also experienced a decline, with Dow Inc down by 333.59 dollars to 42,9.
Sector Update: Health Care Stocks Mixed Pre-Bell Friday
Takeda Pharmaceutical's Hyqvia Approved in Japan for Patients With Immune Disorders
Takeda Gains Approval For HYQVIA In Japan To Treat Immunodeficiency
The Nikkei Average starts up 131 points, with Kawasaki Heavy Industries and SoftBank Group among those rising.
[Nikkei Average Stock Price・TOPIX (Table)] Nikkei Average; 39168.52; +131.67 TOPIX; 2730.96; +3.70 [Opening Overview] On the 25th, the Nikkei average opened with a rebound at 39168.52 yen, up 131.67 yen. The U.S. stock market continued to rise on the previous day, the 24th. The Dow Inc average closed up by 390.08 dollars at 43297.03 dollars, while the Nasdaq finished at 20031.13, up by 266.24 points. Caution arose over the rise in long-term interest rates, and after the opening,
TD Cowen Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating
List of converted stocks (Part 2) [List of converted stocks for Parabolic Signal]
○List of stocks converting to Sell Market Code Stock Name Closing Price SAR Main Board <1720> Tokyu Construction 700 715 <1803> Shimizu Construction 1215 1248 <1878> Daito Construction 1767 518225 <1882> Toa Road 1280 1311 <1925> Daiwa House 4717 4849 <1928> Sekisui House 3579 3730 <1934> Euretec 1436 1472 <1952
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
Takeda Pharmaceutical: Revised Extraordinary Report
ADR Japanese stock rankings - general Sell pressure including Yuucho Bank, Chicago down 145 yen compared to Osaka at 39,255 yen.
Japanese stocks of ADR (American Depositary Receipt) compared to the Tokyo Stock Exchange (calculated at 153.48 yen per dollar) include Yu-cho Bank <7182>, SoftBank Group <9984>, Nidec <6594>, Renesas <6723>, Sony Group Corp <6758>, Murata Manufacturing <6981>, DAIKIN INDUSTRIES, LTD. Unsponsored ADR <6367>, all of which have declined, indicating a general trend towards Sell. The clearing price for Chicago Nikkei 225 Futures is down 145 yen from the Osaka daytime price, now at 39,255 yen. The U.S. stock market has fallen. The Dow Inc decreased by 267.58 dollars, now at 43,449.
Takeda Pharmaceutical (TAK.US) CD38 monoclonal antibody has been approved for clinical use again in China.
Takeda Pharmaceutical's CD38 monoclonal antibody has been approved for clinical use in China again.
Regarding the launch of the strategic partnership "Project Soten" between Takeda Pharmaceutical and Tohoku Universities to accelerate the research and development of Innovative Drugs.
On December 17, 2024, Takeda Pharmaceuticals Sp Adr and Tohoku University announced the launch of a strategic alliance "Project Sōten" to accelerate research and development of Innovative Drugs - Building an advanced clinical trial acceleration model aimed at improving medical access for regional patients and strengthening domestic drug development capabilities - Accelerating the establishment of a medical network and healthcare data infrastructure centered on Tohoku University Hospital, promoting research and development of new drugs and treatments through integrated analysis, and contributing to the world from Tohoku.
Takeda Pharmaceutical Unveils $10 Billion-$20 Billion Late-Stage Pipeline
6-K: Takeda Spotlights High-Value, Late-Stage Pipeline Accelerating the Development of Potential Transformative Treatments for Patients in Multiple Therapeutic Areas
HUTCHMED (China) to Receive $10 Million Milestone Payment From Takeda After First European Reimbursement for Fruzaqla